Support Group

Catheter-related infections, such as Central Line-Associated Bloodstream Infections (CLABSIs) and Catheter-Associated Urinary Tract Infections (CAUTIs), are among the most common and dangerous healthcare-associated infections (HAIs). These infections can lead to severe complications, prolonged hospital stays, and increased mortality. Chlorhexidine Gluconate (CHG) wipes have emerged as a powerful tool in the prevention of these specific infections. Used for skin antisepsis before the insertion of a central line or urinary catheter, CHG wipes effectively reduce the microbial flora on the patient's skin, thereby minimizing the risk of pathogens entering the body at the insertion site. The persistent antimicrobial action of CHG is particularly valuable in this context, as it provides ongoing protection against colonization by microorganisms. Beyond the initial insertion, CHG wipes are also used for daily site maintenance and cleaning around the catheter, which is a critical part of preventing infections in the long term. Their ease of use and standardized application protocol make them a preferred choice for nurses and other healthcare professionals who manage catheters. The implementation of CHG wipes into catheter care bundles and protocols has been widely recommended by health organizations and has shown a significant reduction in infection rates. This focused application of CHG wipes highlights their targeted effectiveness in addressing some of the most critical challenges in infection control. For more information on the clinical evidence and market's focus on this application, you can consult the detailed Chlorhexidine Gluconate Wipes Market report.